These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26456902)

  • 1. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
    Brenner H; Jansen L
    J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
    Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
    Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leading cancers--changes in five-year relative survival.
    Ellison LF; Gibbons L
    Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.
    Brenner H
    Lancet; 2002 Oct; 360(9340):1131-5. PubMed ID: 12387961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjusting relative survival estimates for cancer mortality in the general population.
    Ellison LF
    Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
    Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
    J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
    Lake J; Mak V; Møller H; Davies EA
    Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
    Brenner H; Söderman B; Hakulinen T
    Int J Epidemiol; 2002 Apr; 31(2):456-62. PubMed ID: 11980816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage at diagnosis and early mortality from cancer in England.
    McPhail S; Johnson S; Greenberg D; Peake M; Rous B
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
    Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
    Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
    Brenner H; Hakulinen T
    Am J Epidemiol; 2006 Oct; 164(7):689-96. PubMed ID: 16840519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry.
    Ellison LF
    Ann Epidemiol; 2006 Mar; 16(3):191-6. PubMed ID: 16099673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.